Storage and handling
Tamper resistant for your protection. Use only if seal is intact.
Tamper resistant for your protection. Use only if seal is intact.
Drug Facts__________________________________________________________________________________________________________
HPUS active ingredients: Absinthium, Adenosinum cyclophosphoricum, Adrenalinum, Adrenocorticotrophin, Allium cepa, Ambrosia artemisiifolia, Caulophyllum thalictroides, Conium maculatum, Cortisone aceticum, Euphrasia officinalis, Fagopyrum esculentum, Galphimia glauca, Histaminum hydrochloricum, Kali muriaticum, Melilotus officinalis, Mucosa nasalis suis, Natrum muriaticum, RNA, Rumex crispus, Sabadilla and Secale cornutum. Equal volumes of each ingredient in 12X, 30X, and 1LM potencies.
Uses for temporary relief of allergy symptoms commonly
experienced in KS, ND, NE, SD: █ itchy, watery eyes █ runny
nose █ sneezing █ sore throat █ sinus congestion █ cough
█ stuffy nose █ fatigue █ itchy, irritated skin █ hoarseness
█ headache.
Inactive Ingredients:
Bio-Energetically Enhanced™ pure
water, citrus extract* (ascorbic
acid, citric acid, citrus aurantium
amara fruit extract, citrus
aurantium sinensis peel extract,
citrus reticulata fruit extract,
demineralized water, glycerin,
lactic acid), Honeysuckle (Lonicera
japonica), polylysine, Shagbark
Hickory (Carya ovata) Bark
Extract, steviol (Steviol
glycosides).
Warnings
If pregnant or breast-feeding, ask a healthcare professional
before use.
Keep out of reach of children. In case of overdose, get
medical help or contact a Poison Control Center immediately.
Directions
Tamper resistant for your protection. Use only if seal is intact.
Equal volumes of each HPUS** ingredient in 12X, 30X, and 1LM
potencies unless otherwise noted.
Absinthium................................................itchy eyes, sore throat
Adenosinum cyclophosphoricum..............headache, runny nose
Adrenalinum ...........hay fever, swollen sinuses, lung congestion
Adrenocorticotrophin (30X) ............................congestion, cough
Allium cepa........................hay fever, sinus headache, sneezing
Ambrosia artemisiaefolia......................hay fever, wheezy cough
Caulophyllum thalictroides ...............hoarseness, panting breath
Conium maculatum ............. sick headache, shortness of breath
Cortisone aceticum.............................allergic reaction, irritability
Euphrasia officinalis.....................discharge from eyes and nose
Fagopyrum esculentum...................red, itching eyes, headache
Galphimia glauca................................swollen eyelids, hay fever
Histaminum hydrochloricum............. coughing fits, itching throat
Kali muriaticum....................hoarseness, stuffy nose, nosebleed
Melilotus officinalis................... congestive headache, dry cough
Mucosa nasalis suis ..............sinus headache, nasal congestion
Natrum muriaticum...................................watery eyes, sneezing
RNA..................................................................allergic reactions
Rumex crispus...............raw throat with much mucus, dry cough
Sabadilla...........................sore throat, runny nose, sneezing fits
Secale cornutum ........................pain in lungs, difficult breathing
**“HPUS” indicates the active ingredients are in the official
Homeopathic Pharmacopeia of the United States.
Questions? Call 866.298.2740
King Bio, Inc. • 3 Westside Drive
Asheville, NC 28806 USA
FDA Reg. #1053442
For latest product information
and instructions, visit
www.DrKings.com
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 57955-0755-2 | 2022-01-28 | C162847 | 48780-1 | 9d75b9d0-f65b-f424-e053-dadaa90a57ce | Regional Allergies Plains U.S. |
| 57955-2710-2 | 2020-07-08 | C162847 | 48780-1 | 9d75b9d0-f65b-f424-e053-dadaa90a57ce | Regional Allergies Plains U.S. |
| 57955-2710-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-f65b-f424-e053-dadaa90a57ce | Regional Allergies Plains U.S. |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 57955-0755-2 | Allergies Plains U.S. | 1 in 1 CARTON | LIQUID | 1 | 4 | |
| 57955-0755-2 | Allergies Plains U.S. | 59 mL in 1 BOTTLE, SPRAY | LIQUID | 59 | 4 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 57955-0755 | ALLERGIES PLAINS U.S. (ABSINTHIUM, ADENOSINUM CYCLOPHOSPHORICUM, ADRENALINUM, ADRENOCORTICOTROPHIN, ALLIUM CEPA, AMBROSIA ARTEMISIIFOLIA, CAULOPHYLLUM THALICTROIDES, CONIUM MACULATUM, CORTISONE ACETICUM, EUPHRASIA OFFICINALIS, FAGOPYRUM ESCULENTUM, GALPHIMIA GLAUCA, HISTAMINUM HYDROCHLORICUM, KALI MURIATICUM, MELILOTUS OFFICINALIS, MUCOSA NASALIS SUIS, NATRUM MURIATICUM, RNA, RUMEX CRISPUS, SABADILLA, SECALE CORNUTUM) LIQUID [KING BIO INC.] | 4 | Legacy NDC, 2 package rows | 20200709_bfb98751-515d-4bbe-869f-6e29b38b3de6.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ADENOSINE CYCLIC PHOSPHATE | ACTIVE INGREDIENT | E0399OZS9N | 1 | |
| AMBROSIA ARTEMISIIFOLIA | ACTIVE INGREDIENT | 9W34L2CQ9A | 1 | |
| CAULOPHYLLUM THALICTROIDES ROOT | ACTIVE INGREDIENT | JTJ6HH6YEH | 1 | |
| CLAVICEPS PURPUREA SCLEROTIUM | ACTIVE INGREDIENT | 01G9XEA93N | 1 | |
| CONIUM MACULATUM FLOWERING TOP | ACTIVE INGREDIENT | Q28R5GF371 | 1 | |
| CORTICOTROPIN | ACTIVE INGREDIENT | K0U68Q2TXA | 1 | |
| CORTISONE ACETATE | ACTIVE INGREDIENT | 883WKN7W8X | 1 | |
| EPINEPHRINE | ACTIVE INGREDIENT | YKH834O4BH | 1 | |
| EUPHRASIA STRICTA | ACTIVE INGREDIENT | C9642I91WL | 1 | |
| FAGOPYRUM ESCULENTUM | ACTIVE INGREDIENT | B10M69172N | 1 | |
| GALPHIMIA GLAUCA FLOWERING TOP | ACTIVE INGREDIENT | 93PH5Q8M7E | 1 | |
| HISTAMINE DIHYDROCHLORIDE | ACTIVE INGREDIENT | 3POA0Q644U | 1 | |
| MELILOTUS OFFICINALIS TOP | ACTIVE INGREDIENT | GM6P02J2DX | 1 | |
| ONION | ACTIVE INGREDIENT | 492225Q21H | 1 | |
| POTASSIUM CHLORIDE | ACTIVE INGREDIENT | 660YQ98I10 | 1 | |
| RUMEX CRISPUS ROOT | ACTIVE INGREDIENT | 9N1RM2S62C | 1 | |
| SACCHAROMYCES CEREVISIAE RNA | ACTIVE INGREDIENT | J17GBZ5VGX | 1 | |
| SCHOENOCAULON OFFICINALE SEED | ACTIVE INGREDIENT | 6NAF1689IO | 1 | |
| SODIUM CHLORIDE | ACTIVE INGREDIENT | 451W47IQ8X | 1 | |
| SUS SCROFA NASAL MUCOSA | ACTIVE INGREDIENT | ID3Z1X61WY | 1 | |
| WORMWOOD | ACTIVE INGREDIENT | F84709P2XV | 1 | |
| ADENOSINE CYCLIC 3',5'-PHOSPHATE | ACTIVE MOIETY | E0399OZS9N | 1 | |
| AMBROSIA ARTEMISIIFOLIA | ACTIVE MOIETY | 9W34L2CQ9A | 1 | |
| CAULOPHYLLUM THALICTROIDES ROOT | ACTIVE MOIETY | JTJ6HH6YEH | 1 | |
| CHLORIDE ION | ACTIVE MOIETY | Q32ZN48698 | 1 | |
| CLAVICEPS PURPUREA SCLEROTIUM | ACTIVE MOIETY | 01G9XEA93N | 1 | |
| CONIUM MACULATUM FLOWERING TOP | ACTIVE MOIETY | Q28R5GF371 | 1 | |
| CORTICOTROPIN | ACTIVE MOIETY | K0U68Q2TXA | 1 | |
| CORTISONE | ACTIVE MOIETY | V27W9254FZ | 1 | |
| EPINEPHRINE | ACTIVE MOIETY | YKH834O4BH | 1 | |
| EUPHRASIA STRICTA | ACTIVE MOIETY | C9642I91WL | 1 | |
| FAGOPYRUM ESCULENTUM | ACTIVE MOIETY | B10M69172N | 1 | |
| GALPHIMIA GLAUCA FLOWERING TOP | ACTIVE MOIETY | 93PH5Q8M7E | 1 | |
| HISTAMINE | ACTIVE MOIETY | 820484N8I3 | 1 | |
| MELILOTUS OFFICINALIS TOP | ACTIVE MOIETY | GM6P02J2DX | 1 | |
| ONION | ACTIVE MOIETY | 492225Q21H | 1 | |
| POTASSIUM CATION | ACTIVE MOIETY | 295O53K152 | 1 | |
| RUMEX CRISPUS ROOT | ACTIVE MOIETY | 9N1RM2S62C | 1 | |
| SACCHAROMYCES CEREVISIAE RNA | ACTIVE MOIETY | J17GBZ5VGX | 1 | |
| SCHOENOCAULON OFFICINALE SEED | ACTIVE MOIETY | 6NAF1689IO | 1 | |
| SUS SCROFA NASAL MUCOSA | ACTIVE MOIETY | ID3Z1X61WY | 1 | |
| WORMWOOD | ACTIVE MOIETY | F84709P2XV | 1 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | 1 | |
| POTASSIUM SORBATE | INACTIVE INGREDIENT | 1VPU26JZZ4 | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 57955-0755 | 57955-0755-2 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, SOLUTION / INTRAVENOUS | 772 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | FILM, SOLUBLE / BUCCAL | 2 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | CAPSULE / ORAL | 131 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SPRAY / NASAL | 5 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | FILM / SUBLINGUAL | 11 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SUSPENSION/ DROPS / ORAL | 15 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, ORALLY DISINTEGRATING / ORAL | 46 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SOLUTION / ORAL | 1000 mg/15ml | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION / INTRAMUSCULAR | 101 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | PASTE / ORAL | 48 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SPRAY, METERED / NASAL | 0.06 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | LOTION / TOPICAL | 0.2 %w/w | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 414 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | LOZENGE / TRANSMUCOSAL | 44 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET / ORAL | 197 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION / INFILTRATION | 0.02 %w/v | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SUSPENSION / RECTAL | 904 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION / INTRAVENOUS | 1152 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, EFFERVESCENT / ORAL | 840 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | FILM / BUCCAL | 9 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | LIQUID / INTRAVENOUS | 18 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | GEL / TOPICAL | 3 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION / ORAL | 3900 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SUSPENSION, EXTENDED RELEASE / ORAL | 62 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SUSPENSION / ORAL | 400 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | CONCENTRATE / INTRAVENOUS | ADJ PH | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | GRANULE, FOR SUSPENSION / ORAL | 80 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SOLUTION/ DROPS / OPHTHALMIC | 0.47 %w/v | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | FILM, SOLUBLE / ORAL | 7 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | CAPSULE, LIQUID FILLED / ORAL | 360 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | CAPSULE / ORAL | NA | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION / RESPIRATORY (INHALATION) | 5 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET / BUCCAL | 30 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 48 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, ORALLY DISINTEGRATING / SUBLINGUAL | ADJ PH | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | GRANULE, FOR SUSPENSION / ORAL | 30 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION / OPHTHALMIC | 0.09 %w/v | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SUSPENSION / RESPIRATORY (INHALATION) | 1 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET / SUBLINGUAL | 36 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | PASTE / ORAL | 26 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | POWDER, FOR SOLUTION / ORAL | 123 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SOLUTION / RECTAL | 6.67 %w/v | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SUSPENSION/ DROPS / OPHTHALMIC | 0.05 %w/v | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, EXTENDED RELEASE / ORAL | 0.2 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, COATED / ORAL | NA | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SUSPENSION / ORAL | 400 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION / PERINEURAL | 0.02 %w/v | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | CONCENTRATE / ORAL | 1 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | EMULSION / OPHTHALMIC | 0.47 %w/v | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION / INTRACARDIAC | 25 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | CONCENTRATE / ORAL | 84 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SHAMPOO / TOPICAL | 0.07 %w/w | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SYRUP / ORAL | 2 mg/1ml | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | LOTION / TOPICAL | 211 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SYRUP / ORAL | 268 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, SOLUTION / SUBCUTANEOUS | 25 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, SOLUTION / INTRAMUSCULAR | 25 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION, CONCENTRATE / INTRAVENOUS | 60 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | OIL / TOPICAL | 2 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 12 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| b92fe569-ff94-4d3a-8992-48962bf455e7 | bfb98751-515d-4bbe-869f-6e29b38b3de6 | 2026-10-02 | Warnings | bfb98751-515d-4bbe-869f-6e29b38b3de6 |
Adverse event summaries are temporarily unavailable. Other product information remains available.